| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,645 | 11,357 | 11,292 | 11,002 | | Cost of Revenue | 3,746 | 3,633 | 3,824 | 2,961 | | | Gross Profit | 7,899 | 7,724 | 7,468 | 8,041 | | | Operating Expenses | | Research Development | 2,438 | 2,263 | 2,529 | 2,212 | | Selling General and Administrative | 9,294 | 9,751 | 9,779 | 10,503 | | Non Recurring |
-
|
-
| 3,081 |
-
| | Others | 756 | 738 | 700 | 465 | | | | Total Operating Expenses |
-
|
-
| 16,089 |
-
| | | | Operating Income or Loss | (4,589) | (5,028) | (8,621) | (5,139) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (52) | (94) | (180) | 9 | | Earnings Before Interest And Taxes | (4,641) | (5,122) | (8,801) | (5,130) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,641) | (5,122) | (8,801) | (5,130) | | Income Tax Expense | 20 | 26 | 29 | 36 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,661) | (5,148) | (8,830) | (5,166) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,661) | (5,148) | (8,830) | (5,166) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,661) | ($5,148) | ($8,830) | ($5,166) |
|
0.08% Nasdaq 
0.43%
Income Statement
